3923 Results

People

  1. Brennan
    Brennan
  2. Gonen
    Gonen
  3. Zelefsky
    Zelefsky
  4. D'Angelica
    D'Angelica
  5. Jarnagin
    Jarnagin
  6. Shah
    Shah
  7. Wolden
    Wolden
  8. Shaha
    Shaha
  9. Motzer
    Motzer
  10. Lee
    Lee

Groups

  1. Surgery (1555)
  2. Department of Medicine (1472)
  3. Survivorship Research (1046)
  4. Solid Tumor Oncology Division (830)
  5. Epidemiology and Biostatistics (660)
  6. Population Sciences Research Program (543)
  7. Center for Hematologic Malignancies (499)
  8. Department of Pathology and Laboratory Medicine (482)
  9. Hematologic Malignancies, Division of (472)
  10. Biostatistics Service (469)
  1. "follow up"
Formats
  1. Journal Article (3648)
  2. Review (81)
  3. Research Letter (66)
  4. Editorial (54)
  5. Correspondence (26)
  6. Conference Paper (24)
  7. Guidelines (20)
  8. Meeting Abstract (2)
  9. Book Section (1)
  10. Miscellaneous (1)
Groups
  1. Surgery (1555)
  2. Department of Medicine (1472)
  3. Survivorship Research (1046)
  4. Solid Tumor Oncology Division (830)
  5. Epidemiology and Biostatistics (660)
  6. Population Sciences Research Program (543)

More Groups

People
  1. Mithat Gonen (115)
  2. Murray Brennan (115)
  3. Michael Zelefsky (108)
  4. Michael D'Angelica (93)
  5. William Jarnagin (91)
  6. Jatin Shah (87)

More People

Years
  1. 2025 (177)
  2. 2024 (416)
  3. 2023 (219)
  4. 2022 (151)
  5. 2021 (89)
  6. 2020 (195)

More Years

Publications
  1. Annals of Surgical Oncology (208)
  2. Journal of Clinical Oncology (203)
  3. International Journal of Radiation Oncology, Biology, Physics (173)
  4. Cancer (160)
  5. Gynecologic Oncology (102)
  6. Journal of Urology (93)

More Publications

Publishers
  1. Elsevier Inc. (667)
  2. Elsevier Science, Inc. (461)
  3. Springer (397)
  4. Wiley Blackwell (320)
  5. Lippincott Williams & Wilkins (294)
  6. American Society of Clinical Oncology (215)

More Publishers

Results (3923)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: A systematic literature review
    Review

    Gay, F.; Zamagni, E.; Cole, C. E.; Scheid, C.; Hultcrantz, M.; Chorazy, J.; Iheanacho, I.; Pandey, A.; Bitetti, J.; Boytsov, N.; more...
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • Management approaches for primary hepatic lymphoma: 10 year institutional experience with comprehensive literature review
    Journal Article

    Ma, J.; Daou, R.; Bou Eid, J.; Fregonese, B.; El-Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • Preoperative unveiling of mucinous ovarian cancer subtypes: Clinical and CT features
    Journal Article

    Causa Andrieu, P.; Hamdan, D.; Hassanzadeh, S.; Balakrishnan, R.; Rodriguez, L.; Zheng, J.; Fernandes, M. C.; Praiss, A.; Gangai, N.; Capanu, M.; more...
    European Journal of Radiology (2025)

    Fulltext@MSK | Save
  • Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies
    Journal Article

    Lopez, J. S.; Milhem, M.; Butler, M. O.; Thistlethwaite, F.; Van Tine, B. A.; D'Angelo, S. P.; Johnson, M. L.; Sato, T.; Arkenau, H. T.; Edukulla, R.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Real-world evidence evaluating teclistamab in patients with relapsed/refractory multiple myeloma: A systematic literature review
    Review

    Derman, B.; Tan, C.; Steinfield, I.; Wilson, F. R.; Lin, D.; Wu, B.; Fernandez, M.; Fowler, J.; Paner-Straseviciute, A.; Kim, N.; more...
    Cancers (2025)

    Fulltext@MSK | Save
  • Multicancer early detection testing: Guidance for primary care discussions with patients
    Review

    Hoffman, R. M.; Wolf, A. M. D.; Raoof, S.; Guerra, C. E.; Church, T. R.; Elkin, E. B.; Etzioni, R. D.; Shih, Y. C. T.; Skates, S. J.; Manassaram-Baptiste, D.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2– early breast cancer
    Journal Article

    Graff, S. L.; Tolaney, S. M.; Hart, L. L.; Razavi, P.; Janni, W.; Schwartzberg, L. S.; Danyliv, A.; Akdere, M.; Ferrusi, I.; Adhikary, R. R.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
    Journal Article

    Shinn, E.; Zahrieh, D.; DeMichele, A.; Zdenkowski, N.; Lemieux, J.; Mao, J.; Bjelic-Radisic, V.; Naughton, M. J.; Pfeiler, G.; Gelmon, K.; more...
    Breast Cancer Research and Treatment (2025)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: A US real-world cohort study
    Journal Article

    Modi, S.; Zhang, S.; Byng, D.; Hunter, S.; Strübing, A.; Xiong, Y.; Dunton, K.; Mbanya, Z.; Jacot, W.
    Breast Cancer Research and Treatment (2025)

    Fulltext@MSK | Save
  • Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): An International Myeloma Working Group Study
    Journal Article

    Tan, C. R.; Asoori, S.; Huang, C. Y.; Brunaldi, L.; Popat, R.; Kastritis, E.; Martinez-Lopez, J.; Bansal, R.; Silva Corraes, A. D. M.; Chhabra, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save